These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 12813443

  • 1. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F, Zeng D, Higuchi M, Higgins JP, Strober S.
    Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
    [Abstract] [Full Text] [Related]

  • 2. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.
    Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S.
    J Immunol; 2001 Aug 15; 167(4):2087-96. PubMed ID: 11489992
    [Abstract] [Full Text] [Related]

  • 3. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Aug 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 4. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion.
    Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, Strober S.
    J Immunol; 2002 Nov 15; 169(10):5564-70. PubMed ID: 12421933
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP, Li Z, Nador RG, Strober S.
    Transplantation; 2008 Feb 27; 85(4):607-14. PubMed ID: 18347541
    [Abstract] [Full Text] [Related]

  • 6. Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.
    Salam A, Waer M.
    Transplantation; 1996 Mar 15; 61(5):826-30. PubMed ID: 8607190
    [Abstract] [Full Text] [Related]

  • 7. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.
    Pillai AB, George TI, Dutt S, Teo P, Strober S.
    J Immunol; 2007 May 15; 178(10):6242-51. PubMed ID: 17475852
    [Abstract] [Full Text] [Related]

  • 8. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB, George TI, Dutt S, Strober S.
    Blood; 2009 Apr 30; 113(18):4458-67. PubMed ID: 19221040
    [Abstract] [Full Text] [Related]

  • 9. Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.
    E S, Seth A, Vogel P, Sommers M, Ong T, Pillai AB.
    Blood; 2017 Jun 01; 129(22):3017-3030. PubMed ID: 28351935
    [Abstract] [Full Text] [Related]

  • 10. Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update.
    Kohrt H, Lowsky R.
    Curr Opin Hematol; 2009 Nov 01; 16(6):460-5. PubMed ID: 19812489
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients.
    Vallera DA, Soderling CC, Carlson GJ, Kersey JH.
    Transplantation; 1982 Mar 01; 33(3):243-8. PubMed ID: 6121405
    [Abstract] [Full Text] [Related]

  • 12. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H, Billiau AD, Overbergh L, Rutgeerts O, Waer M.
    Transplantation; 1999 Nov 27; 68(10):1560-7. PubMed ID: 10589955
    [Abstract] [Full Text] [Related]

  • 13. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW.
    Biol Blood Marrow Transplant; 2017 Sep 27; 23(9):1498-1508. PubMed ID: 28554856
    [Abstract] [Full Text] [Related]

  • 14. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
    van der Merwe M, Abdelsamed HA, Seth A, Ong T, Vogel P, Pillai AB.
    J Immunol; 2013 Dec 01; 191(11):5764-76. PubMed ID: 24190658
    [Abstract] [Full Text] [Related]

  • 15. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC, Song CW, Blazar BR, Vallera DA.
    J Immunol; 1985 Aug 01; 135(2):941-6. PubMed ID: 3891856
    [Abstract] [Full Text] [Related]

  • 16. Comparison of chimeric acid and non-chimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection.
    Hayamizu K, Lan F, Huie P, Sibley RK, Strober S.
    Transplantation; 1999 Oct 15; 68(7):1036-44. PubMed ID: 10532547
    [Abstract] [Full Text] [Related]

  • 17. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
    Neipp M, Gammie JS, Exner BG, Li S, Chambers WH, Pham SM, Ildstad ST.
    Transplantation; 1999 Aug 15; 68(3):369-78. PubMed ID: 10459540
    [Abstract] [Full Text] [Related]

  • 18. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A, Cabrespine A, Socié G, Milpied N, Yakoub Agha I, Nguyen S, Michallet M, Menard AL, Maillard N, Mohty M, Suarez F, Huynh A, Marchand T, Deteix C, Cassuto JP, Maury S, Chevallier P, Reman O, Peffault de Latour R, Bay JO.
    Transplantation; 2016 Aug 15; 100(8):1732-9. PubMed ID: 26528768
    [Abstract] [Full Text] [Related]

  • 19. Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells.
    Rigby SM, Rouse T, Field EH.
    Blood; 2003 Mar 01; 101(5):2024-32. PubMed ID: 12406908
    [Abstract] [Full Text] [Related]

  • 20. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH, Choi EY, Chung DH.
    J Immunol; 2007 Nov 15; 179(10):6579-87. PubMed ID: 17982047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.